Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02176031
Brief Title: Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD

First Submitted : June 25, 2014
First Submitted that Met QC Criteria : June 25, 2014
First Posted : June 26, 2014 (Estimate)

Results First Submitted : March 2, 2020
Results First Submitted that Met QC Criteria : April 7, 2020
Results First Posted : April 17, 2020

Last Update Submitted that Met QC Criteria : April 7, 2020
Last Update Posted : April 17, 2020